To further explore the clinical significance of ARHGAP35, a tissue microarray (n = 150) composed of the same batch of NPC patient tissues used in the previous analysis of FTO and ALKBH5 was adopted. The gene discussed is ARHGAP35; the disease is nasopharyngeal carcinoma.